References
- SvensonURoosGTelomere length as a biological marker in malignancyBiochim Biophys Acta20091792431732319419696
- WentzensenIMMirabelloLPfeifferRMSavageSAThe association of telomere length and cancer: a meta-analysisCancer Epidemiol Biomarkers Prev20112061238125021467229
- KimNWPiatyszekMAProwseKRSpecific association of human telomerase activity with immortal cells and cancerScience19942665193201120157605428
- YamamotoKOkamotoAIsonishiSOchiaiKOhtakeYA novel gene, CRR9, which was up-regulated in CDDP-resistant ovarian tumor cell line, was associated with apoptosisBiochem Biophys Res Commun200128041148115411162647
- MocellinSVerdiDPooleyKATelomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysisJ Natl Cancer Inst20121041184085422523397
- RafnarTSulemPStaceySNSequence variants at the TERT-CLPTM1L locus associate with many cancer typesNat Genet200941222122719151717
- SiegelRLMillerKDJemalACancer Statistics, 2017CA Cancer J Clin201767173028055103
- SuLYLiXLShenLPolymorphisms of TERT and CLPTM1L and the risk of hepatocellular carcinoma in Chinese malesAsian Pac J Cancer Prev201415198197820125339005
- LeeHWParkTIJangSYClinicopathological characteristics of TERT promoter mutation and telomere length in hepatocellular carcinomaMedicine 201965e5766
- BaeEYLeeSYKangBKReplication of results of genome-wide association studies on lung cancer susceptibility loci in a Korean populationRespirology201217469970622404340
- LechelAMannsMPRudolphKLTelomeres and telomerase: new targets for the treatment of liver cirrhosis and hepatocellular carcinomaJ Hepatol200441349149715336455
- YinJLiYYinMTERT-CLPTM1L polymorphism rs401681 contributes to cancers risk: evidence from a meta-analysis based on 29 publicationsPLoS One2012711e5065023226346
- MirabelloLYuKKraftPThe association of telomere length and genetic variation in telomere biology genesHum Mutat20103191050105820597107
- PooleyKATyrerJShahMNo association between TERT-CLPTM1L single nucleotide polymorphism rs4,01,681 and mean telomere length or cancer riskCancer Epidemiol Biomarkers Prev20101971862186520570912
- KoESeoHWJungESKimBHJungGThe TERT promoter SNP rs2853669 decreases E2F1 transcription factor binding and increases mortality and recurrence risks in liver cancerOncotarget20167168469926575952
- AzadAKQiuXBoydKA genetic sequence variant (GSV) at susceptibility loci of 5p15.33 (TERT-CLPTM1L) is associated with survival outcome in locally advanced and metastatic non-small-cell lung cancer (NSCLC)Lung Cancer201484328929424679952
- ZhaoXWangSWuJAssociation of TERT polymorphisms with clinical outcome of non-small cell lung cancer patientsPLoS One2015105e012923226020272
- KachuriLLatifovicLLiuGHungRJSystematic review of genetic variation in chromosome 5p15.33 and telomere length as predictive and prognostic biomarkers for lung cancerCancer Epidemiol Biomarkers Prev201625121537154927566420
- BisoffiMHeaphyCMGriffithJKTelomeres: prognostic markers for solid tumorsInt J Cancer2006119102255226016858685